L-chiro-Inositol, 4-amino-1,4-dideoxy-3-O-(2,6-diamino-2,3,4,6,7-penta deoxy-beta-L-lyxo-heptopyranosyl)-6-O-methyl-1-(2-(formimidoylamino)-N -methylacetamido)-, sulfate (1:2), hydrate Chemische Eigenschaften,Einsatz,Produktion Methoden

Sicherheitsprofil

A poison by intravenous and intramuscular route. Moderately toxic by subcutaneous route. When heated to decomposition it emits toxic vapors of NOx and SOx

L-chiro-Inositol, 4-amino-1,4-dideoxy-3-O-(2,6-diamino-2,3,4,6,7-penta deoxy-beta-L-lyxo-heptopyranosyl)-6-O-methyl-1-(2-(formimidoylamino)-N -methylacetamido)-, sulfate (1:2), hydrate Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

L-chiro-Inositol, 4-amino-1,4-dideoxy-3-O-(2,6-diamino-2,3,4,6,7-penta deoxy-beta-L-lyxo-heptopyranosyl)-6-O-methyl-1-(2-(formimidoylamino)-N -methylacetamido)-, sulfate (1:2), hydrate Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
TargetMol Chemicals Inc.	+1-781-999-5354 +1-00000000000	marketing@targetmol.com	United States	32161	58
BOC Sciences	16314854226; +16314854226	inquiry@bocsci.com	United States	19741	58
Hangzhou MolCore BioPharmatech Co.,Ltd.	+86-057181025280; +8617767106207	sales@molcore.com	China	49734	58

---

• L-chiro-Inositol, 4-amino-1,4-dideoxy-3-O-(2,6-diamino-2,3,4,6,7-penta deoxy-beta-L-lyxo-heptopyranosyl)-6-O-methyl-1-(2-(formimidoylamino)-N -methylacetamido)-, sulfate (1:2), hydrate
• Dactimicin sulfate
• Antibiotic SF 2052 sulfate
• SF-2052 sulfate
• 73245-91-7